Maze Therapeutics annual net profit margin
2024
Maze Therapeutics's net profit margin was 31.18% for fiscal 2024.
View full Maze Therapeutics company overview| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 31.18% | — |
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −121.04% | — |
| Q3 2024 | 2024-09-30 | −990.08% | — |
| Q2 2024 | 2024-06-30 | 84.28% | — |
The latest reported quarter, Q1 2026, shows −121.04%.
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maze Therapeutics source filings ↗